Smoldering Multiple Myeloma Latest Advances

Find the Latest Research About Smoldering Multiple Myeloma

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 750 publications

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Journal: Expert review of hematology
Published: August 05, 2026

Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.

Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.

Journal: Future oncology (London, England)
Published: August 04, 2026

High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.

High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 31, 2026

Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management.

Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management.

Journal: American journal of hematology
Published: July 30, 2026

Not all methods for identifying high-risk smoldering myeloma measure up.

Not all methods for identifying high-risk smoldering myeloma measure up.

Journal: Cancer
Published: July 27, 2026

Necrobiotic Xanthogranuloma Associated With IgG Kappa Smoldering Myeloma Presenting as Vision-Threatening Orbital Disease: Clinical Response to Plasma Cell-Directed Therapy.

Necrobiotic Xanthogranuloma Associated With IgG Kappa Smoldering Myeloma Presenting as Vision-Threatening Orbital Disease: Clinical Response to Plasma Cell-Directed Therapy.

Journal: Cureus
Published: June 19, 2026

Recent topics in smoldering multiple myeloma: early intervention or active monitoring?

Recent topics in smoldering multiple myeloma: early intervention or active monitoring?

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 03, 2026

Free Light Chain Monomer-Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression.

Free Light Chain Monomer-Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression.

Journal: Cancers
Published: June 01, 2026

Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early Intervention.

Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early Intervention.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 22, 2026

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma.

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma.

Journal: Leukemia
Published: May 09, 2026

Ultra-High-Resolution Dual-Source Photon-Counting CT for Expanded Characterization of Pathophysiological Imaging Patterns in Multiple Myeloma.

Ultra-High-Resolution Dual-Source Photon-Counting CT for Expanded Characterization of Pathophysiological Imaging Patterns in Multiple Myeloma.

Journal: Investigative radiology
Published: May 05, 2026

Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

Journal: Research square
Published: April 27, 2026
Showing 1-12 of 750

Last Updated: 09/19/2026